OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of North Carolina - Chapel Hill

3 Projects | 1 Researchers | $876,694 Invested

2005

University of North Carolina - Chapel Hill

Frank Longo, MD, PhD

NGF Small Molecule Mimetics: Preclinical Studies

  • Funding Amount: $195,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2004

University of North Carolina - Chapel Hill

Frank Longo, MD, PhD

BDNF Small Molecule Mimetics

  • Funding Amount: $160,177
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2000

University of North Carolina - Chapel Hill

Frank Longo, MD, PhD

Alzheimer's Therapeutics: Neurotrophin Small Molecule Mimetics

  • Funding Amount: $521,517
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed